Case Study: World's Largest Pharmaceutical Company achieves full endpoint visibility and cuts investigation time from 30+ days to hours with Cybereason

World Largest Pharmaceutical Company - Customer Case Study

World Largest Pharmaceutical Company, a nearly $100B global pharma leader, faced urgent cybersecurity risks protecting perishable products and a vast portfolio of R&D and clinical-trial IP while under persistent, sophisticated attacks from competitors and nation-states. To address these challenges the customer turned to Cybereason, deploying Cybereason’s enterprise detection and response capabilities and the Cybereason Active Monitoring service for rapid, flexible visibility.

Cybereason delivered full attack-lifecycle detection and monitoring across the environment, giving the company correlated visibility for 500,000+ endpoints and the ability to detect previously unseen attacks. As a result investigations dropped from more than 30 days to a few hours, incidents fully understood rose from 35% to 90%, daily machine re-imaging fell by 90%, and three security FTEs were freed for higher-value work.